Abbott Diabetes Care
Clinical trials sponsored by Abbott Diabetes Care, explained in plain language.
Develops glucose monitoring devices for diabetes.
Not investment advice. Company information is shown for context only. Clinical trials frequently fail.
Advertising disclosure. Links marked "(ad)" go to partners we have a commercial relationship with, either a broker where you can trade or a stock-research service, and we may earn a commission if you open an account or subscribe. This never affects what is shown here.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- Glucose monitor study aims to uncover hidden signs of prediabetes Results expected Dec 2026 (estimated)
- New glucose monitor aims to prevent dangerous low blood sugar in kids Results expected Dec 2026 (estimated)
-
New glucose monitor helps type 2 diabetes patients on insulin
Disease control CompletedThis study looked at whether starting the FreeStyle Libre 2 continuous glucose monitor helps adults with type 2 diabetes who use basal insulin. Over three months, researchers measured changes in HbA1c and time spent in healthy blood sugar range. The study included 90 adults aged …
Sponsor: Abbott Diabetes Care • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
Which blood sugar meter is best? major study puts 5 devices to the test
Knowledge-focused CompletedThis study tested five different blood glucose meters in 501 adults with type 1 or type 2 diabetes who use insulin. Participants used multiple devices to see how accurate and reliable each meter is in real-world conditions. The goal was to help people with diabetes and their doct…
Sponsor: Abbott Diabetes Care • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:00 UTC